Page last updated: 2024-10-21

huperzine a and Neuroblastoma

huperzine a has been researched along with Neuroblastoma in 7 studies

huperzine A: RN given refers to 5R-(5alpha,9beta,11E)-isomer; structure given in first source
huperzine A : A sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity. It is also an effective inhibitor of acetylcholinesterase and has attracted interest as a therapeutic candidate for Alzheimer's disease.

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
" We investigated the effects of the acetylcholinesterase inhibitor, huperzine A (Hup A), on APP processing and Abeta generation in human neuroblastoma SK-N-SH cells overexpressing wild-type human APP695."7.74Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. ( Jiang, L; Lee, DY; Lemere, CA; Ma, Z; Peng, Y; Schachter, SC, 2007)
"Alzheimer's disease is a worldwide metabolic disease and an economically costly disease to society, so more medicines need to be developed to treat this disease."5.39Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells. ( Fang, L; Jiang, H; Tao, Y; Yang, H; Yang, Y; Zhang, H; Zhou, H, 2013)
" We investigated the effects of the acetylcholinesterase inhibitor, huperzine A (Hup A), on APP processing and Abeta generation in human neuroblastoma SK-N-SH cells overexpressing wild-type human APP695."3.74Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. ( Jiang, L; Lee, DY; Lemere, CA; Ma, Z; Peng, Y; Schachter, SC, 2007)
"Alzheimer's disease is a worldwide metabolic disease and an economically costly disease to society, so more medicines need to be developed to treat this disease."1.39Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells. ( Fang, L; Jiang, H; Tao, Y; Yang, H; Yang, Y; Zhang, H; Zhou, H, 2013)
"Huperzine A (HupA) is a reversible and selective inhibitor of acetylcholinesterase (AChE), and it has multiple targets when used for Alzheimer's disease (AD) therapy."1.37Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. ( Teng, WP; Wang, CY; Wang, SL; Wang, T; Wang, ZY; Xie, JW; Zhao, BL; Zheng, W, 2011)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Dang, TK1
Hong, SM1
Dao, VT1
Nguyen, DT1
Nguyen, KV1
Nguyen, HT1
Ullah, S1
Tran, HT1
Kim, SY1
Tao, Y1
Fang, L1
Yang, Y1
Jiang, H1
Yang, H1
Zhang, H1
Zhou, H1
Wang, CY1
Zheng, W1
Wang, T1
Xie, JW1
Wang, SL1
Zhao, BL1
Teng, WP1
Wang, ZY1
Zhao, HW1
Li, XY1
Zhang, HY1
Brimijoin, S1
Tang, XC2
Tang, LL1
Wang, R1
Peng, Y1
Lee, DY1
Jiang, L1
Ma, Z1
Schachter, SC1
Lemere, CA1

Other Studies

7 other studies available for huperzine a and Neuroblastoma

ArticleYear
Neuroprotective effects of total alkaloids fraction of Huperzia serrata on scopolamine-induced neurodegenerative animals.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:1

    Topics: Acetylcholinesterase; Alkaloids; Animals; Antioxidants; Humans; Huperzia; Mice; Neuroblastoma; Neuro

2023
Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells.
    Proteomics, 2013, Volume: 13, Issue:8

    Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Databases, Protein; Down-R

2013
Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:5

    Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Prec

2011
Ginkgolide A, B, and huperzine A inhibit nitric oxide-induced neurotoxicity.
    International immunopharmacology, 2002, Volume: 2, Issue:11

    Topics: Alkaloids; Apoptosis; Brain Neoplasms; Cell Division; Diterpenes; Flow Cytometry; Ginkgolides; Human

2002
Apoptosis induced by beta-amyloid25-35 in acetylcholinesterase-overexpressing neuroblastoma cells.
    Acta pharmacologica Sinica, 2003, Volume: 24, Issue:9

    Topics: Acetylcholinesterase; Alkaloids; Amyloid beta-Peptides; Animals; Apoptosis; Cell Survival; Cholinest

2003
Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production.
    European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2

    Topics: Alkaloids; Androstadienes; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Carbazol

2005
Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
    Neuroscience, 2007, Dec-05, Volume: 150, Issue:2

    Topics: ADAM Proteins; ADAM10 Protein; ADAM17 Protein; Alkaloids; Alzheimer Disease; Amyloid beta-Peptides;

2007